
Ozicef-S 250mg/125mg Injection
Marketer
Skyways Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ozicef-S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), a dual-action antibiotic, combats various bacterial infections. This medication inhibits microbial growth, curbing infection spread. Administration must be under a doctor's direct supervision; missed doses should be avoided. Complete the prescribed course, even with symptom improvement; premature cessation may reduce efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; worsening symptoms require immediate medical attention. Allergic reactions (skin rashes, itching, swelling, breathing difficulties) demand immediate medical help. Inform your physician about all other medications prior to use. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption may increase drowsiness. While typically not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are crucial for recovery. Your doctor may order blood tests and other diagnostics to monitor treatment effectiveness.
Uses of Ozicef-S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ozicef-S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ozicef-S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ozicef-S 250mg/125mg Injection:
Administering this medication will be performed by your physician or their designated nurse; self-medication is strictly prohibited.
How Ozicef-S 250mg/125mg Injection works:
The injectable formulation Ozicef-S, containing 250mg of Ceftriaxone and 125mg of Sulbactam, employs a dual-drug approach. Ceftriaxone, a key antibiotic component, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by counteracting bacterial resistance mechanisms, thereby amplifying its antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Ozicef-S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Ozicef-S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects remain scarce.
Breast feedingCAUTION
The administration of Ozicef-S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ozicef-S 250mg/125mg Injection could lead to drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ozicef-S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The Ozicef-S 250mg/125mg Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Altering the dose of Ozicef-S 250mg/125mg Injection is not advised for those experiencing mild or moderate liver dysfunction.
What if you forget to take Ozicef-S 250mg/125mg Injection :
Omitting a scheduled Ozicef-S 250mg/125mg Injection requires immediate physician consultation.
Facts to Know About Ozicef-S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
